Committee & speakers
Speakers
Below an overview of the speakers. This overview will be updated regularly.
Juan Fuego
Chief, Section of Experimental Neuro-Oncology
University of Texas MD Anderson Cancer Center, Houston Texas, USA
Francesca Barone
Chief Scientific Officer
Candel Therapeutics, USA
Robert Coffin
Founder and Chief Scientist
Replimune, USA
Richard Vile
Professor of Immunology
Mayo Clinic
Guido Kroemer
Director of the team 'Metabolism, Cancer & Immunity' / Director of the Metabolomics and Cell Biology Platforms
Université de Paris, Sorbonne Université, Paris, France / Institut Gustave Roussy, Villejuif, France
Abhishek D Garg
Research Assistant Professor
KU Leuven, Belgium
Stephen Russell
CEO
Vyriad, Inc.
E. Antonio Chiocca
Chair, Department of Neurosurgery; Harvey W. Cushing Professor of Neurosurgery, Harvard Medical School
Brigham and Women’s Hospital
Local Organizing Committee IOVC2024
Below an overview of the committee. This overview will be updated regularly.
Clemens Dirven
Chair at the Department of Neurosurgery
Erasmus MC
Martine Lamfers
Symposium Chair, Associate Professor, Head Neurosurgery Lab
Erasmus MC
Bernadette van den Hoogen
Associate Professor at the Department of Viroscience
Erasmus MC
Rob C. Hoeben
Professor of Gene Transfer
Leiden University Medical Center
Scientific Committee of the IOVC
Below an overview of the committee. This overview will be updated regularly.
Samuel D. Rabkin
Professor of Neurosurgery
Massachusetts General Hospital and Harvard Medical School, Boston MA
Alan Melcher
Professor of Translational Immunotherapy
The Institute of Cancer Research, London
E. Antonio Chiocca
Chair, Department of Neurosurgery; Harvey W. Cushing Professor of Neurosurgery, Harvard Medical School
Brigham and Women’s Hospital
Evanthia Galanis
Professor of Oncology and Sandra J. Schultze Professor of Novel Therapeutics
Mayo Clinic
Brian Lichty
Associate Professor
McMaster University
Tomoki Todo
Professor and Hospital Director
Division of Innovative Cancer Therapy, and Department of Surgical Neuro-Oncology The Institute of Medical Science The University of Tokyo
Stephen Russell
CEO
Vyriad, Inc.
David Stojdl
Founder, Senior Vice President Research and Senior Scientific Fellow
Turnstone Biologics Inc.
